IDXX Revenue Flow
Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.
- 2026-06-30: Revenue $1.22B; Revenue including tax (m); Cost of revenue $437.50M; Research and development $65.43M.
- 2026-03-31: Revenue $1.14B; Revenue including tax (m); Cost of revenue $418.08M; Research and development $65.79M.
- 2025-12-31: Revenue $1.09B*; Revenue including tax (m); Cost of revenue $432.46M*; Research and development $66.83M*.
- 2025-09-30: Revenue $1.11B; Revenue including tax (m); Cost of revenue $421.88M; Research and development $63.41M.
Consolidation item
Separate filed amounts; connecting flows are not established. Components and totals may overlap.
Product or service
Separate filed amounts; connecting flows are not established. Components and totals may overlap.
Geography
Separate filed amounts; connecting flows are not established. Components and totals may overlap.
Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.
Historical revenue and expense breakdown
Revenue and expense 3 month
| Period end | Revenue | Revenue including tax | Cost of revenue | Research and development | Operating expenses | Income tax | Net income |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.22B | (m) | $437.50M | $65.43M | $353.52M | $78.81M | $338.41M |
| 2026-03-31 | $1.14B | (m) | $418.08M | $65.79M | $360.15M | $77.00M | $278.45M |
| 2025-12-31 | $1.09B* | (m) | $432.46M* | $66.83M* | $342.51M* | $58.79M* | $248.19M* |
| 2025-09-30 | $1.11B | (m) | $421.88M | $63.41M | $328.51M | $70.16M | $274.61M |
| 2025-06-30 | $1.11B | (m) | $414.73M | $61.90M | $321.69M | $68.36M | $293.99M |
| 2025-03-31 | $998.43M | (m) | $375.05M | $59.06M | $306.85M | $67.41M | $242.68M |
| 2024-09-30 | $975.54M | (m) | $379.50M | $53.98M | $292.15M | $66.07M | $232.84M |
| 2024-06-30 | $1.00B | (m) | $384.42M | $55.45M | $355.36M | $55.76M | $203.30M |
| 2024-03-31 | $964.10M | (m) | $371.02M | $52.63M | $294.11M | $59.90M | $235.58M |
| 2023-09-30 | $915.53M | (m) | $367.55M | $47.97M | (m) | $55.66M | $212.23M |
| 2023-06-30 | $943.63M | (m) | $370.78M | $46.51M | (m) | $61.69M | $224.24M |
| 2023-03-31 | $900.20M | (m) | $357.22M | $44.67M | (m) | $53.63M | $214.05M |
| 2022-09-30 | $841.66M | (m) | $335.04M | $48.01M | (m) | $53.24M | $180.94M |
| 2022-06-30 | $860.55M | (m) | $346.51M | $123.22M | (m) | $39.10M | $131.98M |
| 2022-03-31 | $836.55M | (m) | $337.80M | $40.17M | (m) | $47.53M | $193.97M |
| 2021-09-30 | $810.42M | (m) | $337.50M | $40.43M | (m) | $43.77M | $175.24M |
| 2021-06-30 | $826.14M | (m) | $336.83M | $37.70M | (m) | $49.13M | $202.58M |
| 2021-03-31 | $777.71M | (m) | $306.93M | $37.58M | (m) | $35.80M | $204.26M |
| 2020-09-30 | $721.79M | (m) | $299.18M | $37.52M | (m) | $17.63M | $146.22M |
| 2020-06-30 | $637.59M | (m) | $258.25M | $31.64M | (m) | $34.83M | $148.94M |
| 2020-03-31 | $626.34M | (m) | $266.75M | $33.31M | (m) | $24.92M | $111.83M |
| 2019-12-31 | $605.45M | (m) | (m) | (m) | (m) | (m) | $90.50M |
| 2019-09-30 | $605.30M | (m) | $260.35M | $34.26M | (m) | $23.96M | $108.84M |
| 2019-06-30 | $620.10M | (m) | $262.25M | $32.26M | (m) | $30.42M | $125.71M |
| 2019-03-31 | $576.06M | (m) | $244.46M | $31.51M | (m) | $22.08M | $102.68M |
| 2018-12-31 | $549.39M | (m) | (m) | (m) | $185.01M* | (m) | $85.64M |
| 2018-09-30 | $545.45M | (m) | $239.81M | $29.19M | $188.29M | $15.82M | $93.25M |
| 2018-06-30 | $580.75M | $580.75M | $248.31M | $29.51M | (m) | $28.63M | $108.69M |
| 2018-03-31 | $537.66M | $537.66M | $234.56M | $29.02M | (m) | $14.87M | $89.45M |
| 2017-12-31 | $506.12M | (m) | (m) | (m) | (m) | (m) | $38.26M |
| 2017-09-30 | $491.98M | (m) | $217.97M | $27.59M | (m) | $21.54M | $70.51M |
| 2017-06-30 | $508.94M | $508.94M | $216.22M | $27.00M | (m) | $29.18M | $85.36M |
| 2017-03-31 | $462.02M | $462.02M | $203.83M | $25.79M | (m) | $15.68M | $69.02M |
| 2016-12-31 | $443.00M | (m) | (m) | (m) | (m) | (m) | $52.37M |
| 2016-09-30 | $448.31M | (m) | $201.58M | $25.67M | (m) | $25.07M | $56.45M |
| 2016-06-30 | $466.57M | (m) | $206.03M | $25.41M | (m) | $29.68M | $67.20M |
| 2016-03-31 | $417.55M | (m) | $190.01M | $24.62M | (m) | $20.28M | $46.02M |
| 2015-12-31 | $399.69M | (m) | (m) | (m) | (m) | (m) | $44.35M |
| 2015-09-30 | $406.39M | (m) | $182.11M | $24.86M | (m) | $20.60M | $44.22M |
| 2015-06-30 | $413.34M | (m) | $180.59M | $24.32M | (m) | $24.66M | $56.91M |
| 2015-03-31 | $382.48M | (m) | $166.93M | $25.01M | (m) | $20.35M | $46.59M |
| 2014-12-31 | $351.96M | (m) | (m) | (m) | (m) | (m) | $25.96M |
| 2014-09-30 | $383.52M | (m) | $170.19M | $24.85M | (m) | $16.05M | $52.14M |
| 2014-06-30 | $390.12M | (m) | $171.60M | $25.43M | (m) | $23.50M | $57.22M |
| 2014-03-31 | $360.20M | (m) | $158.11M | $23.11M | (m) | $21.15M | $46.59M |
| 2013-12-31 | $354.07M | (m) | (m) | (m) | (m) | (m) | $43.26M |
| 2013-09-30 | $338.30M | (m) | $152.51M | $21.57M | (m) | $18.79M | $45.69M |
| 2013-06-30 | $352.58M | (m) | $154.88M | $22.18M | (m) | $24.03M | $53.99M |
| 2013-03-31 | $332.11M | (m) | $148.13M | $21.76M | (m) | $15.93M | $44.86M |
| 2012-12-31 | $319.54M | (m) | (m) | (m) | (m) | (m) | $43.35M |
| 2012-09-30 | $315.48M | (m) | $144.84M | $20.35M | (m) | $19.64M | $42.85M |
| 2012-06-30 | $335.65M | (m) | $150.96M | $20.06M | (m) | $24.05M | $51.32M |
| 2012-03-31 | $322.68M | (m) | $147.90M | $20.56M | (m) | $18.92M | $40.74M |
| 2011-12-31 | $307.20M | (m) | (m) | (m) | (m) | (m) | $38.01M |
| 2011-09-30 | $300.95M | (m) | $142.29M | $19.41M | (m) | $17.12M | $38.51M |
| 2011-06-30 | $317.86M | (m) | $143.83M | $18.62M | (m) | $22.28M | $48.66M |
| 2011-03-31 | $292.67M | (m) | $137.75M | $17.81M | (m) | $16.57M | $36.61M |
| 2010-12-31 | $283.76M | (m) | (m) | (m) | (m) | (m) | $36.37M |
| 2010-09-30 | $269.63M | (m) | $127.42M | $17.20M | (m) | $14.55M | $34.69M |
| 2010-06-30 | $281.48M | (m) | $132.20M | $17.21M | (m) | $17.09M | $37.19M |
| 2010-03-31 | $268.52M | (m) | $126.16M | $16.71M | (m) | $15.09M | $33.03M |
| 2009-09-30 | $259.12M | (m) | $128.64M | $16.58M | (m) | $12.28M | $31.54M |
| 2009-06-30 | $265.72M | (m) | $127.28M | $16.59M | (m) | $15.11M | $33.67M |
Revenue and expense 6 month
| Period end | Revenue | Revenue including tax | Cost of revenue | Research and development | Operating expenses | Income tax | Net income |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.36B | (m) | $855.58M | $131.22M | $713.67M | $155.81M | $616.86M |
| 2025-06-30 | $2.11B | (m) | $789.77M | $120.96M | $628.53M | $135.77M | $536.67M |
| 2024-06-30 | $1.97B | (m) | $755.44M | $108.08M | $649.47M | $115.66M | $438.88M |
| 2023-06-30 | $1.84B | (m) | $728.00M | $91.17M | (m) | $115.33M | $438.29M |
| 2022-06-30 | $1.70B | (m) | $684.31M | $163.39M | (m) | $86.63M | $325.94M |
| 2021-06-30 | $1.60B | (m) | $643.76M | $75.28M | (m) | $84.93M | $406.84M |
| 2020-06-30 | $1.26B | (m) | $525.00M | $64.95M | (m) | $59.74M | $260.77M |
| 2019-06-30 | $1.20B | (m) | $506.71M | $63.77M | (m) | $52.50M | $228.39M |
| 2018-06-30 | $1.12B | $1.12B | $482.87M | $58.53M | (m) | $43.50M | $198.14M |
| 2017-06-30 | $970.96M | $970.96M | $420.06M | $52.79M | (m) | $44.86M | $154.38M |
| 2016-06-30 | $884.12M | (m) | $396.04M | $50.03M | (m) | $49.96M | $113.22M |
| 2015-06-30 | $795.82M | (m) | $347.52M | $49.32M | (m) | $45.01M | $103.51M |
| 2014-06-30 | $750.33M | (m) | $329.71M | $48.55M | (m) | $44.65M | $103.80M |
| 2013-06-30 | $684.69M | (m) | $303.02M | $43.94M | (m) | $39.96M | $98.85M |
| 2012-06-30 | $658.33M | (m) | $298.86M | $40.62M | (m) | $42.97M | $92.06M |
| 2011-06-30 | $610.53M | (m) | $281.58M | $36.43M | (m) | $38.85M | $85.27M |
| 2010-06-30 | $550.01M | (m) | $258.36M | $33.91M | (m) | $32.17M | $70.22M |
| 2009-06-30 | $502.18M | (m) | $239.31M | $32.53M | (m) | $27.08M | $59.74M |
Revenue and expense 9 month
| Period end | Revenue | Cost of revenue | Research and development | Operating expenses | Income tax | Net income |
|---|---|---|---|---|---|---|
| 2025-09-30 | $3.21B | $1.21B | $184.37M | $957.04M | $205.93M | $811.28M |
| 2024-09-30 | $2.94B | $1.13B | $162.06M | $941.62M | $181.73M | $671.72M |
| 2023-09-30 | $2.76B | $1.10B | $139.14M | (m) | $170.99M | $650.52M |
| 2022-09-30 | $2.54B | $1.02B | $211.40M | (m) | $139.88M | $506.88M |
| 2021-09-30 | $2.41B | $981.26M | $115.70M | (m) | $128.70M | $582.07M |
| 2020-09-30 | $1.99B | $824.18M | $102.47M | (m) | $77.38M | $406.99M |
| 2019-09-30 | $1.80B | $767.06M | $98.03M | (m) | $76.46M | $337.22M |
| 2018-09-30 | $1.66B | $722.67M | $87.72M | $565.19M | $59.33M | $291.39M |
| 2017-09-30 | $1.46B | $638.03M | $80.37M | (m) | $66.39M | $224.89M |
| 2016-09-30 | $1.33B | $597.62M | $75.70M | (m) | $75.04M | $169.68M |
| 2015-09-30 | $1.20B | $529.63M | $74.19M | (m) | $65.61M | $147.73M |
| 2014-09-30 | $1.13B | $499.90M | $73.39M | (m) | $60.69M | $155.94M |
| 2013-09-30 | $1.02B | $455.53M | $65.51M | (m) | $58.74M | $144.54M |
| 2012-09-30 | $973.80M | $443.70M | $60.96M | (m) | $62.61M | $134.91M |
| 2011-09-30 | $911.49M | $423.86M | $55.84M | (m) | $55.97M | $123.78M |
| 2010-09-30 | $819.63M | $385.78M | $51.12M | (m) | $46.72M | $104.91M |
| 2009-09-30 | $761.30M | $367.95M | $49.12M | (m) | $39.36M | $91.27M |
Revenue and expense 12 month
| Period end | Revenue | Cost of revenue | Research and development | Operating expenses | Income tax | Net income |
|---|---|---|---|---|---|---|
| 2025-12-31 | $4.30B | $1.64B | $251.21M | $1.30B | $264.73M | $1.06B |
| 2024-12-31 | $3.90B | $1.52B | $219.79M | $1.25B | $221.96M | $887.87M |
| 2023-12-31 | $3.66B | $1.47B | $190.95M | $1.09B | $216.13M | $845.04M |
| 2022-12-31 | $3.37B | $1.36B | $254.82M | $1.11B | $180.88M | $679.09M |
| 2021-12-31 | $3.22B | $1.33B | $161.01M | (m) | $157.81M | $744.85M |
| 2020-12-31 | $2.71B | $1.14B | $141.25M | (m) | $79.85M | $581.78M |
| 2019-12-31 | $2.41B | $1.04B | $133.19M | (m) | $94.43M | $427.72M |
| 2018-12-31 | $2.21B | $971.70M | $117.86M | $750.21M | $80.69M | $377.03M |
| 2017-12-31 | $1.97B | $871.68M | $109.18M | (m) | $117.79M | $263.14M |
| 2016-12-31 | $1.78B | $799.99M | $101.12M | (m) | $99.79M | $222.04M |
| 2015-12-31 | $1.60B | $711.62M | $99.68M | (m) | $81.01M | $192.08M |
| 2014-12-31 | $1.49B | $669.69M | $98.26M | (m) | $64.60M | $181.91M |
| 2013-12-31 | $1.38B | $620.94M | $88.00M | (m) | $75.47M | $187.80M |
| 2012-12-31 | $1.29B | $594.19M | $82.01M | (m) | $82.33M | $178.27M |
| 2011-12-31 | $1.22B | $572.18M | $76.04M | (m) | $72.67M | $161.79M |
| 2010-12-31 | $1.10B | $524.77M | $68.60M | (m) | $60.81M | $141.28M |
| 2009-12-31 | $1.03B | $505.35M | $65.12M | (m) | $52.30M | $122.22M |
| 2008-12-31 | $1.02B | $494.26M | $70.67M | (m) | $54.02M | $116.17M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |